Title
Category
Credits
Event date
Cost
De-prescribing in Primary Care: When, Why, How
  • Disease management
  • Pharmacy benefit management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
This on-demand webcast is designed to equip primary care providers with the knowledge and skills necessary to effectively implement deprescribing practices. It will discuss the challenges of problematic polypharmacy and identify strategies for recognizing deprescribing opportunities, as well as describe the role of governance strategies in deprescribing initiatives. Deprescribing, the process of tapering or stopping medications that may no longer be beneficial or may be causing harm, is crucial for improving patient outcomes and enhancing quality of life.
Understanding Co-occurring Eating Disorders and PTSD: Prevalence, Presentation, and Treatment
  • Behavioral health
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
Research suggests that high comorbidity exists between eating disorders (EDs) and PTSD. In fact, some studies report that up to 90% of individuals suffering from EDs have experienced at least one traumatic event in their lifetime. Those who enter ED treatment with co-occurring PTSD tend to exhibit more severe eating disorder pathology, poorer treatment outcomes, and higher relapse rates compared to those without PTSD. Historically, evidence-based treatment models for EDs have primarily focused on addressing ED symptoms and behaviors, often overlooking co-occurring psychological conditions such as PTSD. However, in recent years, there has been growing recognition within the field of eating disorder treatment of the limitations of this approach. As a result, there is increasing emphasis on integrating evidence- based PTSD treatments into ED treatment to better support individuals with this dual diagnosis. This activity will explore the intersection of EDs and trauma, examine what current research reveals about their co-occurrence and discuss strategies for effectively addressing this complex comorbidity within treatment settings.
Heart Failure: Diagnosis and Initial Management for the Primary Care Provider
  • Cardiology
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
This on-demand webcast is designed to enhance primary care providers’ understanding of the evolving landscape of heart failure classification and treatment. Participants will explore the current nomenclature for heart failure staging and functional classification, with a focus on stratification by ejection fraction. The session will review the latest guideline-directed medical therapy for heart failure with reduced ejection fraction (HFrEF), including updates on pharmacologic and device-based interventions. Additionally, common barriers to implementing optimal therapy will be discussed, along with practical strategies to improve adherence and patient outcomes.
The Role of Optometry in the Management of Diabetes
  • Disease management
  • Vision
  • 1.00 Attendance - General Attendance
  • 1.00 COPE - Optometrists
$0.00
This activity will review the role of optometrists in the areas of prevention, co-management and rehabilitation for individuals with diabetes. It will focus on how to conduct a diabetes risk assessment, ongoing care of individuals with known diabetes and collaboration among members of the interprofessional health care team for optimal outcomes. Key strategies for vision rehabilitation will also be addressed.
EAP 101 for Behavioral Health Providers
  • Behavioral health
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
This activity will provide an overview of the EAP field, history and expansion of services and components of EAP services, and review EAPA standards and code of ethics. The difference between EAP and behavioral health will be examined along with the types of EAP referrals, the benefits of EAP services and the management referral process. EAP core technology, CEAP (certification) and dual relationships will also be discussed.
Understanding OCT-A: Advanced retinal imaging for diabetic eye care
  • Disease management
  • Vision
  • 1.00 Attendance - General Attendance
  • 1.00 COPE - Optometrists
$0.00
Activity descriptionOptical coherence tomography angiography (OCT-A) is a noninvasive imaging test and allows clinicians to detect diseases of the retina that affect the ocular blood vessels at early stages. This activity is designed to enhance clinicians’ understanding and application of OCT-A in practice. Participants will explore the evolution of OCT-A technology, compare it with traditional imaging modalities and examine its clinical relevance.
Advancing Neonatal Care: Implementing the Eat, Sleep, Console (ESC) Method for Neonatal Abstinence Syndrome
  • Disease management
  • Women's health
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
Activity descriptionNeonatal Abstinence Syndrome (NAS) continues to pose significant clinical challenges, with rising incidence rates and prolonged hospital stays. The Eat, Sleep, Console (ESC) method offers a functional, family-centered approach that has demonstrated improved outcomes, including reduced length of stay and decreased medication use.
Heart Failure at the Crossroads: Early Recognition and Proactive Management
  • Disease management
  • 1.25 ACPE - Pharmacists
  • 1.25 ACPE - Pharmacy Technicians
  • 1.25 AMA - Physicians
  • 1.25 ANCC - Nurses
  • 1.25 APA - Psychologists
  • 1.25 Attendance - General Attendance
  • 1.25 ASWB - Social Workers
$0.00
Heart failure remains a leading cause of hospitalization and mortality. This session focuses on recognizing early signs, diagnostic tools, and evidence-based strategies to optimize care, improve patient quality of life, and reduce readmissions.
GLP-1 Agonists in Practice: A New Era in Obesity and Diabetes Management
  • Disease management
  • Wellness
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
GLP-1 receptor agonists have reshaped the landscape of obesity and type 2 diabetes management, offering benefits beyond glycemic control. This session explores their mechanisms, clinical applications, and emerging evidence on their implications for broader metabolic care and in the treatment of obesity-related conditions such as obstructive sleep apnea.
Gene Therapy in the Genomic Era: Promise, Progress and Patient Impact
  • Disease management
  • 1.25 ACPE - Pharmacists
  • 1.25 ACPE - Pharmacy Technicians
  • 1.25 AMA - Physicians
  • 1.25 ANCC - Nurses
  • 1.25 APA - Psychologists
  • 1.25 Attendance - General Attendance
  • 1.25 ASWB - Social Workers
$0.00
Gene therapy technologies are revolutionizing treatment for genetic diseases. This session explores the science, clinical applications, and patient perspectives, with a focus on sickle cell disease and emerging technologies like CRISPR.

Pages